Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 185   

Articles published

AZN 4,407.50 -18.50 (-0.42%)
price chart
Neil Woodford's Risky Portfolio, ft. AstraZeneca plc And Imperial Tobacco ...
AstraZeneca (LSE: AZN), BT Group (LSE: BT-A), Rolls-Royce (LSE: RR) and Imperial Tobacco (LSE: IMT) account for about 23% of Neil Woodford's new equity portfolio.
How AstraZeneca plc Can Pay Off Your Mortgage
AstraZeneca What a difference a year makes! Shares in AstraZeneca (LSE: AZN) (NYSE: AZN.US) are now 30% higher than they were just one year ago, with the performance of the pharmaceutical company easily beating the 1% gains of the FTSE 100 over ...
Related articles »  
Is It Time To Sell AstraZeneca plc?
AstraZeneca Most potential and actual AstraZeneca (LSE: AZN) (NYSE: AZN.US) investors will know that American drugs giant Pfizer tried to take the firm over recently.
AstraZeneca plc Receives Average Rating of "Hold" from Brokerages ...  Watch List News (press release)
AstraZeneca plc Given Average Recommendation of �Hold� by Analysts (NYSE ...  Ticker Report
Related articles »  
Which Bid Target Should You Buy: Shire PLC Or AstraZeneca plc?
shire It's been an extremely busy year for the healthcare sector, as bids for Shire (LSE: SHP) (NASDAQ: SHPG.US) and AstraZeneca (LSE: AZN) (NYSE: AZN.US) have filled a significant amount of column inches. Indeed, both companies have been the ...
1.5 Reasons Why AstraZeneca plc Is A Perilous Income Pick  Yahoo Finance UK
AstraZeneca plc Stock Rating Reaffirmed by Credit Suisse (AZN)  Watch List News (press release)
Related articles »  
AstraZeneca To Collaborate With Advaxis For Cancer
AstraZeneca plc (ADR) (AZN) has announced collaboration with Advaxis, Inc. (ADXS) through its research and development arm MedImmune.
AstraZeneca share price: R&D arm teams up with Advaxis for immuno ...  iNVEZZ
AstraZeneca's MedImmune Teams With Advaxis For Combined Cancer Trial  London South East
Related articles »  
Is Roche Eyeing Up A Bid For AstraZeneca plc?
AstraZeneca's (LSE: AZN) (NYSE: AZN.US) decision to turn down Pfizer's �55 per share takeover offer split opinions.
One Reason Why AstraZeneca plc Is A Risky Bet
AstraZeneca The shares of AstraZeneca (LSE: AZN) (NYSE: AZN.US) trade well above fair value - and that's become even more apparent this week.
Recent practical effects of "just saying no"  Lexology (registration)
Related articles »  
The Rising Pound Will Hit GlaxoSmithKline plc, BHP Billiton plc, ARM Holdings ...
Global research-based pharmaceutical company AstraZeneca (LSE: AZN) is one of them. Of every �1 it earns, less than 9p comes from the UK.
Related articles »  
One Reason Why I Would Buy AstraZeneca plc Today
Of course, adverse regulatory rulings for the likes of AstraZeneca and its peers rarely translate into good news for these firms' investors.
You Won't Believe What Analysts Think About Pfizer Inc. (NYSE:PFE ...  WallStreetPR
Related articles »  
Neil Woodford Still Loves Astrazeneca plc And GlaxoSmithKline plc
AstraZeneca Loyalty is a wonderful thing, and Neil Woodford has bags of it. He has just announced the top 10 holdings in his new CF Woodford Equity Income fund, and the only surprise is how few surprises there are.
AstraZeneca share price: High-profile investor buys into drugmaker  iNVEZZ
Pfizer Critic Boosts AstraZeneca Ties Amid Talk Of New Bid  Law360 (subscription)
Related articles »